Table of Contents
Lung Cancer International
Volume 2016 (2016), Article ID 3086148, 5 pages
http://dx.doi.org/10.1155/2016/3086148
Clinical Study

High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors

1Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Avenue, Toronto, ON, Canada M5G 2M9
2Division of Respirology and Thoracic Surgery, University Health Network, Toronto, ON, Canada
3Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Received 30 March 2016; Accepted 19 June 2016

Academic Editor: Akira Iyoda

Copyright © 2016 Ali Hosni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Celebioglu, O. U. Gurkan, S. Erdogan et al., “High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer,” Japanese Journal of Clinical Oncology, vol. 32, no. 11, pp. 443–448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Reveiz, J.-R. Rueda, and A. F. Cardona, “Palliative endobronchial brachytherapy for non-small cell lung cancer,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD004284, 2012. View at Google Scholar · View at Scopus
  3. C. Hennequin, O. Bleichner, J. Trédaniel et al., “Long-term results of endobronchial brachytherapy: a curative treatment?” International Journal of Radiation Oncology, Biology, Physics, vol. 67, no. 2, pp. 425–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Muto, V. Ravo, G. Panelli, G. Liguori, and G. Fraioli, “High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy,” Oncologist, vol. 5, no. 3, pp. 209–214, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Skowronek, T. Piorunek, M. Kanikowski, A. Chicheł, and G. Bieleda, “Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery,” Brachytherapy, vol. 12, no. 6, pp. 560–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Anacak, N. Mogulkoc, S. Ozkok, T. Goksel, A. Haydaroglu, and U. Bayindir, “High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer,” Lung Cancer, vol. 34, no. 2, pp. 253–259, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kawamura, T. Ebara, H. Katoh et al., “Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma,” Radiation Oncology, vol. 7, article 112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. Villanueva, T. C. M. Lo, and J. F. Beamis Jr., “Endobronchial brachytherapy,” Clinics in Chest Medicine, vol. 16, no. 3, pp. 445–454, 1995. View at Google Scholar · View at Scopus
  9. J. Skowronek, M. Kubaszewska, M. Kanikowski, A. Chicheł, and W. Młynarczyk, “HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer—comparison of two different dose schedules,” Radiotherapy & Oncology, vol. 93, no. 3, pp. 436–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Langendijk, M. K. T. Tjwa, J. M. A. de Jong, G. P. M. Ten Velde, and E. F. M. Wouters, “Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?” Radiotherapy and Oncology, vol. 49, no. 2, pp. 175–183, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. A Phase III, Multi-centre, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy, 2015, https://clinicaltrials.gov/ct2/show/NCT01351116.